Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System

NCT06183684 is registered in ClinicalTrials.gov with Laplace Interventional, Inc as lead sponsor.

NCT NCT06183684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06183684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
Lead sponsor
Laplace Interventional, Inc
Phase
Not applicable
Overall status
Recruiting
Start date
February 19, 2024
Completion date
December 31, 2032
Enrollment
65 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

tricuspid regurgitation